VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹1.69 Cr | ₹41 Cr | ₹42 Cr | ₹43 Cr |
What is the latest Total Debt ratio of VENUS REMEDIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | - |
| Mar2025 | ₹1.69 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹43 Cr |
How is Total Debt of VENUS REMEDIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | - | -100.00 | |
| Mar2025 | ₹1.69 Cr | -95.90 | |
| Mar2024 | ₹41 Cr | -2.29 | |
| Mar2023 | ₹42 Cr | -1.29 | |
| Mar2022 | ₹43 Cr | - | |
Compare Total Debt of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,155.6 Cr | 5.1% | -7% | 261.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 5.1% |
-7% |
261.2% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses